A tripling of response with nivolumab and the first study in which a BRAF/MEK combo increases overall survival are among the melanoma highlights at ESMO 2014, reported by Dr Antoni Ribas.

WebMD's Hansa Bhargava asks CDC's Tom Frieden to comment on current issues in infectious diseases and the changing microbial landscape.

New resources, such as behavioral intervention counseling, can help you convince your patients to take steps to prevent skin cancer.

Jonathan Kay describes a patient with an extensive rash that initially suggested dermatomyositis but turned out to auger something more serious.

Drs. Antoni Ribas and Jeffrey Weber discuss the exceptional data for melanoma in immuno- and targeted therapies presented at ASCO 2014.

Dr. Eric Topol talks with CEO of 23andMe Anne Wojcicki about how her company is challenging the status quo in healthcare.

Dalbavancin -- a new agent in the crowded gram-positive field -- offers advantages when issues arise with compliance or if long-term venous access isn't practical. Dr. Auwaerter offers perspective.

Medscape Editor-in-Chief Eric J. Topol, MD, talks with Siddhartha Mukherjee, MD, PhD, about his career as a researcher and doctor, winning the Pulitzer Prize, and the topic for his next book.

Under the leadership of Dr. Thomas Farley, New York City and Mayor Michael Bloomberg have implemented some of the toughest health laws in the nation.

Nearly 2 decades after the furor over Lucian Leape's 'Error in Medicine,' the number of hospital deaths related to medical errors continues to grow.